COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities - Pages 45-46
Ananda M. Chakrabarty
DOI: http://dx.doi.org/10.6000/1929-2279.2016.05.02.1
Adaptive Edge Detection Technique Towards Features Extraction from Mammogram Images - Pages 47-58
Indra Kanta Maitra, Sangita Bhattacharjee, Debnath Bhattacharyya, Tai-Hoon Kim and Samir Kumar Bandyopadhyay
DOI: http://dx.doi.org/10.6000/1929-2279.2016.05.02.2
Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve) - Pages 59-66
Amoura Abouelnaga, Ghada A. Mutawa, Hassan Abdelghaffar, Mohamed Sobh, Sahar Hamed and Shaker A. Mousa
DOI: http://dx.doi.org/10.6000/1929-2279.2016.05.02.3
Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels - Pages 67-72
Najia Mansoor, Rafeeq Alam Khan, Johannes Schueller, Dagmar Ettlinger, Philipp Buchner, Martin Czejka and Tasneem Ahmad
DOI: http://dx.doi.org/10.6000/1929-2279.2016.05.02.4
|
